Log in to save to my catalogue

AB0764 Malignancy and serious infections among psoriatic arthritis patients treated with biological...

AB0764 Malignancy and serious infections among psoriatic arthritis patients treated with biological...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2033796797

AB0764 Malignancy and serious infections among psoriatic arthritis patients treated with biological drugs in a regional registry in the northwest of spain

About this item

Full title

AB0764 Malignancy and serious infections among psoriatic arthritis patients treated with biological drugs in a regional registry in the northwest of spain

Publisher

Kidlington: Elsevier Limited

Journal title

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.1322

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Limited

More information

Scope and Contents

Contents

BackgroundBiological treatments have provided new opportunities for disease control for patients with psoriatic arthritis. However, it is important to evaluate their safety, since they expose them to an increased risk of developing malignant tumors and serious infections.ObjectivesTo examine the rate of solid tumors and serious infections among pat...

Alternative Titles

Full title

AB0764 Malignancy and serious infections among psoriatic arthritis patients treated with biological drugs in a regional registry in the northwest of spain

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2033796797

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2033796797

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2017-eular.3300

How to access this item